Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11229924 | 1.00 | TRPA1 (0.41) | TRPA1 | |
| SCHEMBL34468073 | 0.97 | TRPA1 (0.39) | TRPA1 | |
| SCHEMBL1760749 | 0.78 | — | — | |
| SCHEMBL1760684 | 0.78 | — | — | |
| SCHEMBL1535132 | 0.78 | — | — | |
| SCHEMBL3627580 | 0.77 | — | — | |
| SCHEMBL6481787 | 0.77 | — | — | |
| SCHEMBL93753 | 0.77 | — | — | |
| SCHEMBL6481571 | 0.77 | — | — | |
| SCHEMBL11705127 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242560-A1 | THERMALLY STABLE RUTHENIUM PRECURSOR COMPOSITION, AND METHOD FOR FORMING RUTHENIUM-CONTAINING FILM | UP CHEMICAL CO., LTD. (KR) | 2023-08-03 | — | — | US | claimed |
| WO-2022080803-A1 | THERMALLY STABLE RUTHENIUM PRECURSOR COMPOSITION, AND METHOD FOR FORMING RUTHENIUM-CONTAINING FILM | 주식회사 유피케미칼 | 2022-04-21 | — | — | WO | claimed |
| US-12522626-B2 | Thermally stable ruthenium precursor composition, and method for forming ruthenium-containing film | UP CHEMICAL CO., LTD. (KR) | 2026-01-13 | — | — | US | disclosed |
| US-20230242560-A1 | THERMALLY STABLE RUTHENIUM PRECURSOR COMPOSITION, AND METHOD FOR FORMING RUTHENIUM-CONTAINING FILM | UP CHEMICAL CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| WO-2022080803-A1 | THERMALLY STABLE RUTHENIUM PRECURSOR COMPOSITION, AND METHOD FOR FORMING RUTHENIUM-CONTAINING FILM | 주식회사 유피케미칼 | 2022-04-21 | — | — | WO | disclosed |
| CN-109232193-A | A method of 3- isopropyl -5- cresols and carvacrol are prepared by 3- carene | 中国林业科学研究院林产化学工业研究所 | 2019-01-18 | — | — | CN | disclosed |
| US-4363747-A | Metallocarborane precursor and catalyst | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1982-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242560-A1 | THERMALLY STABLE RUTHENIUM PRECURSOR COMPOSITION, AND METHOD FOR FORMING RUTHENIUM-CONTAINING FILM | RRP15, RAB35, RNF5 | TRPA1 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.